Articles Companion animals

06 August 2026

Prevalence of Antimicrobial Use in Small Animal Dermatology Referral Practices in the United States.

Clinical evidence update from Veterinary dermatology

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Veterinary dermatology in 2026 evaluated prevalence of Antimicrobial Use in Small Animal Dermatology Referral Practices in the United States..

Key Findings

Antimicrobial resistance is a critical global health concern driven by antimicrobial use. Dermatological conditions are common reasons for antimicrobial prescriptions in small animal practice, yet data on prescribing patterns in veterinary dermatology referral settings are lacking. To characterise the frequency, types and indications for antimicrobial use in dogs and cats seen by board-certified or residency-trained first-opinion veterinary surgeons in the United States. Medical record data about 550 client-owned animals (479 dogs, 71 cats) presenting to 22 US veterinary dermatology referral practices were included. A prospective,...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for canine patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

News of interest

Multilevel analysis of risk factors for clinical mastitis in dairy cows in Plateau State, Nigeria a hierarchical mixed-effects logistic regression modelling approach.

Strategies for Reducing Antimicrobial Use in Cattle Through Gut Microbiome Modulation A Systematic Review of Alternatives to Antibiotics.

Long term safety and efficacy of a functionalized nanogel with endothelin-1 and bradykinin receptor antagonist peptides for treatment of osteoarthritis of the metacarpophalangeal and distal interphalangeal joints in horses

Exploration of the efficacy of eucalyptus oil (micro-capsules) and mangosteen extract against Eimeria tenella infection in chickens.

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

Prevalence of Antimicrobial Use in Small Animal Dermatology Referral Practices in the United States.

Clinical evidence update from Veterinary dermatology

Comments

List

Add

Tag

Related Articles

05 August 2026
Evaluation of neutrophillymphocyte and plateletneutrophil ratios and their prognostic utility in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism.

Evaluation of neutrophillymphocyte and plateletneutrophil ratios and their prognostic utility in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism.

05 August 2026
Therapeutic Outcomes and Owner Assessment in Canine Sebaceous Adenitis Across Breeds A Multicentre Retrospective Analysis and Owner Survey.

Therapeutic Outcomes and Owner Assessment in Canine Sebaceous Adenitis Across Breeds A Multicentre Retrospective Analysis and Owner Survey.

05 August 2026
Effects of bacteriophage supplementation on performance, gut health and blood biochemistry in broilers challenged with necrotic enteritis.

Effects of bacteriophage supplementation on performance, gut health and blood biochemistry in broilers challenged with necrotic enteritis.

04 August 2026
Efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy.

Efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy.

04 August 2026
A retrospective (2020-2025), multicenter study of myxomatous mitral valve disease in Chihuahuas from Italy, Sweden, and the United States of America.

A retrospective (2020-2025), multicenter study of myxomatous mitral valve disease in Chihuahuas from Italy, Sweden, and the United States of America.

More news

Research & Development

Comparison of N-Terminal Pro-B-Type Natriuretic Peptide Between Cats with Cardiogenic Arterial Thromboembolism and Cats with Occult Cardiomyopathy Without Arterial Thromboembolism.

Testicular seminoma clinical, imaging, and histologic features in nine horses.

Stroke test tech receives 'breakthrough' status from FDA

How one rescue dog found new life in a rehab clinic at the Veterinary Teaching Hospital

Newsletter